Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Starbucks
SBUX
|
+$618M |
| 2 |
Vale
VALE
|
+$332M |
| 3 |
CELG
Celgene Corp
CELG
|
+$309M |
| 4 |
CME Group
CME
|
+$306M |
| 5 |
Amazon
AMZN
|
+$290M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$435M |
| 2 |
Meta Platforms (Facebook)
META
|
+$342M |
| 3 |
Crown Castle
CCI
|
+$244M |
| 4 |
SLB Ltd
SLB
|
+$229M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$190M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 16.17% |
| 2 | Technology | 14.41% |
| 3 | Consumer Discretionary | 10.61% |
| 4 | Financials | 10.51% |
| 5 | Real Estate | 9.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2826
EyePoint Inc
EYPT
$1.03B
| $678K | ﹤0.01% |
37,878
-29,285
| -44% | -$696K |
|
|
TPC
2827
Tutor Perini Cor
TPC
$4.41B
| $676K | ﹤0.01% |
+39,500
| New | +$692K |
|
|
UPL
2828
DELISTED
Ultra Petroleum Corp. Common Stock
UPL
| $674K | ﹤0.01% |
1,104,718
+372,318
| +51% | +$271K |
|
2829
VanEck Emerging Markets High Yield Bond ETF
HYEM
$523M
| $671K | ﹤0.01% |
+28,700
| New | +$662K |
|
2830
First Trust Exchange-Traded Fund IV First Trust Tactical High Yield ETF
HYLS
$1.61B
| $669K | ﹤0.01% |
+14,000
| New | +$660K |
|
2831
Optical Cable Corp
OCC
$131M
| $669K | ﹤0.01% |
143,304
+24,689
| +21% | +$107K |
|
2832
Badger Meter
BMI
$3.89B
| $668K | ﹤0.01% |
+12,000
| New | +$667K |
|
|
MBAI
2833
Check-Cap
MBAI
$8.19M
| $668K | ﹤0.01% |
12,372
+6,230
| +101% | +$315K |
|
2834
Highway Holdings
HIHO
$4.07M
| $668K | ﹤0.01% |
201,327
-7,423
| -4% | -$22.8K |
|
2835
Vanguard Long-Term Corporate Bond ETF
VCLT
$8.81B
| $668K | ﹤0.01% |
7,300
-2,500
| -26% | -$220K |
|
2836
Alphatec Holdings
ATEC
$1.46B
| $667K | ﹤0.01% |
251,787
-189,600
| -43% | -$368K |
|
|
USDP
2837
DELISTED
USD PARTNERS LP
USDP
| $665K | ﹤0.01% |
+61,500
| New | +$677K |
|
|
MESO
2838
Mesoblast
MESO
$1.84B
| $663K | ﹤0.01% |
63,150
+30,750
| +95% | +$281K |
|
2839
AMREP Corp
AXR
$123M
| $661K | ﹤0.01% |
114,980
+2,200
| +2% | +$13.4K |
|
|
ALPN
2840
DELISTED
Alpine Immune Sciences Inc
ALPN
| $658K | ﹤0.01% |
95,861
+8,569
| +10% | +$53.4K |
|
|
SDI
2841
DELISTED
Standard Diversified Inc. Class A Common Stock
SDI
| $654K | ﹤0.01% |
34,105
+6,100
| +22% | +$96.9K |
|
|
DLA
2842
DELISTED
Delta Apparel Inc.
DLA
| $651K | ﹤0.01% |
29,300
+15,400
| +111% | +$346K |
|
|
VXRT
2843
DELISTED
Vaxart
VXRT
| $649K | ﹤0.01% |
334,770
+63,608
| +23% | +$121K |
|
2844
Universal Electronics
UEIC
$57.8M
| $646K | ﹤0.01% |
17,400
-1,998
| -10% | -$61.3K |
|
|
ACGN
2845
DELISTED
Aceragen Inc
ACGN
| $646K | ﹤0.01% |
14,906
+11,446
| +331% | +$554K |
|
2846
Willamette Valley Vineyards
WVVI
$12.7M
| $644K | ﹤0.01% |
89,280
+8,576
| +11% | +$61K |
|
|
CCM
2847
Concord Medical Services
CCM
$19.2M
| $643K | ﹤0.01% |
22,930
+50
| +0.2% | +$1.59K |
|
2848
Ovid Therapeutics
OVID
$414M
| $643K | ﹤0.01% |
363,217
+308,117
| +559% | +$771K |
|
2849
Sypris Solutions
SYPR
$42.8M
| $643K | ﹤0.01% |
595,697
+3,000
| +0.5% | +$3.2K |
|
|
HEP
2850
DELISTED
Holly Energy Partners, L.P.
HEP
| $640K | ﹤0.01% |
+23,700
| New | +$689K |
|
Similar funds
Renaissance Technologies's Q1 2019 Portfolio in Review
As of Q1 2019, Renaissance Technologies held 3,883 positions worth $110B, up 20% from $91.3B the previous quarter. Its ten largest holdings account for 8.7% of the portfolio.
Renaissance Technologies deployed $7.09B of net new capital in Q1 2019, opening 532 new positions and adding to 1,751 existing holdings. Its largest new stake was Amazon: 3,483,100 shares worth $310M.
By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 15% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Meta Platforms (Facebook), an estimated $342M trimmed.
- Renaissance Technologies's largest Q1 2019 buy was Amazon: 3,483,100 shares worth $310M.
- Renaissance Technologies added most to Starbucks in Q1 2019, an estimated $618M increase.
- Renaissance Technologies's biggest Q1 2019 reduction was Meta Platforms (Facebook), cutting an estimated $342M.
- Renaissance Technologies fully exited Apple in Q1 2019, selling an estimated $435M.
- Renaissance Technologies's ten largest holdings make up 8.7% of its $110B portfolio in Q1 2019.
- Renaissance Technologies opened 532 new positions and closed 465 in Q1 2019.
- Renaissance Technologies's portfolio value rose 20% quarter-over-quarter to $110B.
Based on Renaissance Technologies's 13F filing for Q1 2019, filed 14 May 2019.